Your browser doesn't support javascript.
loading
Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis Infection.
Mpande, Cheleka A M; Musvosvi, Munyaradzi; Rozot, Virginie; Mosito, Boitumelo; Reid, Timothy D; Schreuder, Constance; Lloyd, Tessa; Bilek, Nicole; Huang, Huang; Obermoser, Gerlinde; Davis, Mark M; Ruhwald, Morten; Hatherill, Mark; Scriba, Thomas J; Nemes, Elisa.
Affiliation
  • Mpande CAM; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Musvosvi M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Rozot V; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Mosito B; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Reid TD; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Schreuder C; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Lloyd T; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Bilek N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Huang H; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California.
  • Obermoser G; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California.
  • Davis MM; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California.
  • Ruhwald M; Statens Serum Institute, Copenhagen, Denmark; and.
  • Hatherill M; Foundation of Innovative New Diagnostics, Geneva, Switzerland.
  • Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Am J Respir Crit Care Med ; 203(12): 1556-1565, 2021 06 15.
Article in En | MEDLINE | ID: mdl-33406011
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Biomarkers / Tumor Necrosis Factor Receptor Superfamily, Member 7 / Latent Tuberculosis / Mycobacterium tuberculosis Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Biomarkers / Tumor Necrosis Factor Receptor Superfamily, Member 7 / Latent Tuberculosis / Mycobacterium tuberculosis Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2021 Document type: Article Affiliation country: Country of publication: